Cerebrospinal Fluid Management Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Age group : Global Opportunity Analysis and Industry Forecast, 2021-2031

Cerebral Spinal Fluid Management Market Research, 2031

The global cerebrospinal fluid management market was valued at $0.67 billion in 2021 and is projected to reach $1.03 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031. Cerebrospinal fluid is an ultrafiltrate of plasma contained within the ventricles of the brain that performs vital functions like providing nourishment, waste removal, and protection to the brain. The excess cerebrospinal fluid building up within the fluid-containing cavities or ventricles of the brain can give rise to the condition like hydrocephalus.  The adult CSF volume is estimated to be about 150 ml, with a distribution of 125 ml within the subarachnoid spaces and 25 ml within the ventricles. When excess CSF builds up around the brain, it can create harmful pressures on the tissues of the brain confined within the skull. The accumulation of CSF occurs due to either an increase in production of the fluid, a decrease in its rate of absorption or it can also accumulate from a condition that blocks its normal flow through the ventricular system.

Market Dynamics

The Cerebrospinal Fluid Management Market Trends such as rise in the growth & innovations in the medical device sector for the adoption of cerebral spinal fluid management devices owing to a massive pool of neurological disease incidences which creates an opportunity for the Cerebrospinal Fluid Management Industry. Rise in the launch of new products made up of advanced technology by various key players in the Cerebrospinal Fluid Management Industry is set to affect the market growth positively. For instance, in May 2020, Aesculap, Inc., in partnership with The Christoph Miethke GmbH & Co. KG announced the launch of the M.blue valve. It was the latest generation of Hydrocephalus valve technology. Its unique gravitational technology was integrated with a fixed differential pressure unit in one valve, allowing for a simple, position-dependent solution. The growth of the cerebral spinal fluid management market is also expected to be driven by high potential in adoption of the technology in developing countries due to increase in the prevalence of CSF related disorders, increase in number of market players, and surge in demand for CSF management. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare technologies, significant investments by government to improve medical technology sector, and development of strong foothold of medical device industries in emerging countries. In addition, the cost effectiveness of the devices and the treatment service may also decide the adoption of the devices. For instance, KIMS Hospital in India suggested the total cost of CSF shunt going by brain shunt, cerebral shunt and hydrocephalus shunt in India (particularly in Hyderabad) may start with $0.5 million. The price for the brain shunt cost or cerebral shunt also called CSF shunt in Hyderabad may vary from other parts of India. Hence, the cost effectiveness factor for cerebral spinal fluid management is attributed to further support the market growth.

The demand for cerebral spinal fluid management is not only limited to developed countries due to the cost effectivity but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the Cerebrospinal Fluid Management Market Size. Factors such as rise in adoption of CSF management devices among the geriatric patients and increase in awareness toward CSF related risks further drive the growth of the Cerebrospinal Fluid Management Market Size. Furthermore, rise in consumer awareness related to geriatric healthcare supported by the government funding or reimbursement also boosts the adoption of cerebral spinal fluid management. Moreover, an increase in research activities by manufacturers for developing innovative solutions in cerebral spinal fluid management technology is expected to fuel their adoption in the near future.

However, the complications related to the proper functioning of the CSF shunts and its life span from the period of implantation among the healthcare professionals and target patient population are hampering the Cerebrospinal Fluid Management Market Growth. Moreover, the presence of another alternative operation called endoscopic third ventriculostomy is anticipated to hamper the growth of the market.

The cerebral spinal fluid management market is segmented into Type and Age group.

The cerebral spinal fluid management market is segmented on the basis of type, age group and region. On the basis of type, the market is bifurcated into CSF shunts and external drainage system. On the basis of age group, the market is classified into pediatric and adult. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

By Type

The CSF shunts segment dominated the global Cerebrospinal Fluid Management Market Share in 2021 and is expected to remain dominant throughout the Cerebrospinal Fluid Management Market Forecast period, owing to increase in adoption of CSF shunts for the treatment of the conditions like hydrocephalus and availability of several types of devices developed by various key players in the market. Moreover, the rise in the prevalence of the neurological diseases that are in direct or indirect association with the volume & pressure of cerebral spinal fluid, growth in awareness regarding the device implantation with less or zero complications involved and availability of cost effective cerebral spinal fluid management devices for implantation also contributes in the growth of the market.

By Age Group

The adult segment held the largest Cerebrospinal Fluid Management Market Share in 2021 and is expected to remain dominant throughout the Cerebrospinal Fluid Management Market Analysis period, owing to the rise in the adult population suffering from neurological diseases, rise in the healthcare expenditure, rise in the disposable income among the developing and developed countries, increase in the support by the government authorities and reimbursements policies for the treatment services of the neurological disorders, and rise in the admissions  of the adult patients in the hospitals and ambulatory surgery centers for the implantation or revision of the cerebral spinal fluid management devices during and post COVID-19 pandemic situation. For instance, according to the data by National Institute of Health, in April 2022, the global incidence of hydrocephalus was estimated to be 85/100,000 people which was stratified by age. It was estimated as 175/100,000 patients for adults and 400/100,000 patients for elderly over the age of 80 with incidence expected to rise in areas with an ageing population.

By Region

In 2021, North America was the dominant region and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of neurodegenerative conditions such as Alzheimer’s disease, ischemic and traumatic brain injury, and neuroinflammatory conditions such as multiple sclerosis, increase in the number of market players and surge in the number of products available in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the number of chances of suffering from neurological conditions and the increasing number of strategies and trends adopted by the market players.  

COMPETITION ANALYSIS

Competitive analysis and profiles of the major players in the cerebral spinal fluid management, such as B. Braun Melsungen AG, Delta Surgical, G. SURGIWEAR LTD, Integra Lifesciences Holdings, Medtronic plc, Moller Medical GMBH, Natus Medical Incorporated, Spiegelberg GmbH & Co. KG, Tokibo Co., Ltd., Wellong Pharma are provided in this report. There are some important players in the market such as Medtronic plc, B. Braun Melsungen AG, Integra Lifesciences Holdings, Natus Medical Incorporated. Various players have adopted strategies like acquisition as key developmental strategies to improve the product portfolio of the cerebral spinal fluid management market.  

Acquisitions in the market

In July 2019, Integra LifeSciences Holdings Corporation, announced that it has acquired Arkis Biosciences Inc. The acquisition of Arkis Biosciences strengthens Integra’s offerings in neurocritical care and Integra’s position as the world leader in advanced catheter technology.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cerebral spinal fluid management market analysis from 2021 to 2031 to identify the prevailing Cerebrospinal Fluid Management Market Opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cerebral spinal fluid management market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cerebral spinal fluid management market trends, key players, market segments, application areas, and market growth strategies.

  Cerebrospinal Fluid Management Market Report Highlights

Aspects	Details
Market Size By 2031	USD 1 billion
Growth Rate	CAGR of 4.4%
Forecast period	2021 - 2031
Report Pages	220
By Type	CSF shunts External drainage system
By Age group	Pediatric Adult
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	Delta Surgical, Natus Medical Incorporated, Möller Medical GmbH, G. Surgiwear Ltd., Integra LifeSciences Holdings, Spiegelberg GmbH & Co. KG, B. Braun Melsungen AG, Tokibo Co.,Ltd, Wellona Pharma, Medtronic plc
Other Players	Moller Medical GMBH, G. SURGIWEAR LTD,   Wellong Instruments Co., Ltd.

Analyst Review

This section provides opinions of the top-level CXOs in the cerebral spinal fluid management market. In accordance to several interviews conducted, the cerebrospinal fluid (CSF) is a body fuel found in the brain and spinal cord, which provides mechanical and immunological protection to the brain. Various management devices are used such as CSF shunts and external drainage systems, which manage the flow of CSF in the body away from the ventricles in a controlled manner, thus preventing abnormal accumulation of CSF or hydrocephalus. The increase in the prevalence of hydrocephalus has helped in driving the growth of the market. 

Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the increase in the research and development activities expenditure for the development of the new products that increases the adoption rate of CSF management including the CSF shunts, increase in awareness about the hydrocephalus treatment among the non-developed and developing countries and increase in government support on research activities and other related trends adopted by the market players. 

Author Name(s) : Prathmesh Bhasme| Avinash Gadekar | Roshan Deshmukh

Related Tags

• Surgical Equipment
• Implantable Drug Delivery
• Implantable Devices
• Neurology